118 related articles for article (PubMed ID: 9638148)
1. The roles of vif and ORF-A genes and AP-1 binding site in in vivo replication of feline immunodeficiency virus.
Inoshima Y; Miyazawa T; Mikami T
Arch Virol; 1998; 143(4):789-95. PubMed ID: 9638148
[TBL] [Abstract][Full Text] [Related]
2. Roles of the auxiliary genes and AP-1 binding site in the long terminal repeat of feline immunodeficiency virus in the early stage of infection in cats.
Inoshima Y; Kohmoto M; Ikeda Y; Yamada H; Kawaguchi Y; Tomonaga K; Miyazawa T; Kai C; Umemura T; Mikami T
J Virol; 1996 Dec; 70(12):8518-26. PubMed ID: 8970975
[TBL] [Abstract][Full Text] [Related]
3. In vivo functions of the auxiliary genes and regulatory elements of feline immunodeficiency virus.
Inoshima Y; Miyazawa T; Mikami T
Vet Microbiol; 1998 Feb; 60(2-4):141-53. PubMed ID: 9646446
[TBL] [Abstract][Full Text] [Related]
4. Absence of
Cano-Ortiz L; Maletich Junqueira D; Comerlato J; Zani A; Santos Costa C; Michel Roehe P; Franco AC
Viruses; 2018 May; 10(6):. PubMed ID: 29857485
[TBL] [Abstract][Full Text] [Related]
5. Expression of feline immunodeficiency virus Vif is associated with reduced viral mutation rates without restoration of replication of vif mutant viruses.
Paul TA; Casey JW; Avery RJ; Sutton CA
Virology; 2007 Apr; 361(1):112-22. PubMed ID: 17169394
[TBL] [Abstract][Full Text] [Related]
6. A feline immunodeficiency virus vif-deletion mutant remains attenuated upon infection of newborn kittens.
Shen X; Leutenegger CM; Stefano Cole K; Pedersen NC; Sparger EE
J Gen Virol; 2007 Oct; 88(Pt 10):2793-2799. PubMed ID: 17872533
[TBL] [Abstract][Full Text] [Related]
7. Accessory genes confer a high replication rate to virulent feline immunodeficiency virus.
Troyer RM; Thompson J; Elder JH; VandeWoude S
J Virol; 2013 Jul; 87(14):7940-51. PubMed ID: 23658451
[TBL] [Abstract][Full Text] [Related]
8. Feline immunodeficiency virus ORF-Ais required for virus particle formation and virus infectivity.
Gemeniano MC; Sawai ET; Leutenegger CM; Sparger EE
J Virol; 2003 Aug; 77(16):8819-30. PubMed ID: 12885901
[TBL] [Abstract][Full Text] [Related]
9. Protective immunity against feline immunodeficiency virus induced by inoculation with vif-deleted proviral DNA.
Lockridge KM; Chien M; Dean GA; Stefano Cole K; Montelaro RC; Luciw PA; Sparger EE
Virology; 2000 Jul; 273(1):67-79. PubMed ID: 10891409
[TBL] [Abstract][Full Text] [Related]
10. Replacement of feline foamy virus bet by feline immunodeficiency virus vif yields replicative virus with novel vaccine candidate potential.
Ledesma-Feliciano C; Hagen S; Troyer R; Zheng X; Musselman E; Slavkovic Lukic D; Franke AM; Maeda D; Zielonka J; Münk C; Wei G; VandeWoude S; Löchelt M
Retrovirology; 2018 May; 15(1):38. PubMed ID: 29769087
[TBL] [Abstract][Full Text] [Related]
11. The feline immunodeficiency virus vif gene is required for productive infection of feline peripheral blood mononuclear cells and monocyte-derived macrophages.
Lockridge KM; Himathongkham S; Sawai ET; Chienand M; Sparger EE
Virology; 1999 Aug; 261(1):25-30. PubMed ID: 10441553
[TBL] [Abstract][Full Text] [Related]
12. Vif of feline immunodeficiency virus from domestic cats protects against APOBEC3 restriction factors from many felids.
Zielonka J; Marino D; Hofmann H; Yuhki N; Löchelt M; Münk C
J Virol; 2010 Jul; 84(14):7312-24. PubMed ID: 20444897
[TBL] [Abstract][Full Text] [Related]
13. Vaccination with vif-deleted feline immunodeficiency virus provirus, GM-CSF, and TNF-alpha plasmids preserves global CD4 T lymphocyte function after challenge with FIV.
Maksaereekul S; Dubie RA; Shen X; Kieu H; Dean GA; Sparger EE
Vaccine; 2009 Jun; 27(28):3754-65. PubMed ID: 19464559
[TBL] [Abstract][Full Text] [Related]
14. Construction and in vitro characterization of attenuated feline immunodeficiency virus long terminal repeat mutant viruses.
Bigornia L; Lockridge KM; Sparger EE
J Virol; 2001 Jan; 75(2):1054-60. PubMed ID: 11134320
[TBL] [Abstract][Full Text] [Related]
15. Identification of a Cullin5-ElonginB-ElonginC E3 complex in degradation of feline immunodeficiency virus Vif-mediated feline APOBEC3 proteins.
Wang J; Zhang W; Lv M; Zuo T; Kong W; Yu X
J Virol; 2011 Dec; 85(23):12482-91. PubMed ID: 21957297
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the vif gene of feline immunodeficiency virus.
Shacklett BL; Luciw PA
Virology; 1994 Nov; 204(2):860-7. PubMed ID: 7941360
[TBL] [Abstract][Full Text] [Related]
17. Feline Immunodeficiency Virus Evolutionarily Acquires Two Proteins, Vif and Protease, Capable of Antagonizing Feline APOBEC3.
Yoshikawa R; Takeuchi JS; Yamada E; Nakano Y; Misawa N; Kimura Y; Ren F; Miyazawa T; Koyanagi Y; Sato K
J Virol; 2017 Jun; 91(11):. PubMed ID: 28331087
[TBL] [Abstract][Full Text] [Related]
18. Vaccination of cats with attenuated feline immunodeficiency virus proviral DNA vaccine expressing gamma interferon.
Gupta S; Leutenegger CM; Dean GA; Steckbeck JD; Cole KS; Sparger EE
J Virol; 2007 Jan; 81(2):465-73. PubMed ID: 17079309
[TBL] [Abstract][Full Text] [Related]
19. Feline Immunodeficiency Virus Vif N-Terminal Residues Selectively Counteract Feline APOBEC3s.
Gu Q; Zhang Z; Cano Ortiz L; Franco AC; Häussinger D; Münk C
J Virol; 2016 Dec; 90(23):10545-10557. PubMed ID: 27630243
[TBL] [Abstract][Full Text] [Related]
20. Ability of CD8+ T cell anti-feline immunodeficiency virus (FIV) activity and FIV proviral DNA load in mononuclear cells in FIV-infected cats.
Hohdatsu T; Nakanishi T; Saito I; Koyama H
J Vet Med Sci; 2005 Jan; 67(1):129-31. PubMed ID: 15699611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
